Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isolation and Propagation of Human Corneal Stromal Keratocytes for Tissue Engineering and Cell Therapy. | Cells | 2022 | 35011740 | PubTator, text mining | PubMed |
| Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome. | EBioMedicine | 2022 | 34954656 | PubTator, text mining | PubMed |
| Decreased FABP5 and DSG1 protein expression following PAX6 knockdown of differentiated human limbal epithelial cells. | Exp Eye Res | 2022 | 34954205 | PubTator, text mining | PubMed |
| A commentary on the paper: 'Evaluation of spice and herb as phytoderived selective modulators of human retinaldehyde dehydrogenases using a simple in vitro method'. | Biosci Rep | 2022 | 34940794 | PubTator, text mining | PubMed |
| Immunotoxicity and uterine transcriptome analysis of the effect of zearalenone (ZEA) in sows during the embryo attachment period. | Toxicol Lett | 2022 | 34933075 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma. | Biochem Genet | 2022 | 34928471 | PubTator, text mining | PubMed |
| Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids. | Nucleic Acids Res | 2022 | 34893868 | PubTator, text mining | PubMed |
| Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis. | Mol Cancer Res | 2022 | 34670863 | PubTator, text mining | PubMed |
| High expression of SARS-CoV2 viral entry-related proteins in human limbal stem cells. | Ocul Surf | 2022 | 34653711 | PubTator, text mining | PubMed |
| Regenerative therapy for the Cornea. | Prog Retin Eye Res | 2022 | 34530154 | PubTator, text mining | PubMed |
| Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells. | Anticancer Drugs | 2022 | 34419959 | PubTator, text mining | PubMed |
| Mass spectrometry-based tear proteomics for noninvasive biomarker discovery. | Mass Spectrom Rev | 2022 | 33759206 | PubTator, text mining | PubMed |
| Wound healing of the corneal epithelium: a review. | Asian Biomed (Res Rev News) | 2021 | 37551323 | PubTator, text mining | PubMed |
| Layered double hydroxide-based nanocomposite scaffolds in tissue engineering applications. | RSC Adv | 2021 | 35480250 | PubTator, text mining | PubMed |
| A Mixture of Baicalein, Wogonin, and Oroxylin-A Inhibits EMT in the A549 Cell Line via the PI3K/AKT-TWIST1-Glycolysis Pathway. | Front Pharmacol | 2021 | 35222014 | PubTator, text mining | PubMed |
| Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology. | Front Pharmacol | 2021 | 35126150 | PubTator, text mining | PubMed |
| Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance. | Front Pharmacol | 2021 | 35126099 | PubTator, text mining | PubMed |
| NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. | Nat Cancer | 2021 | 35122061 | PubTator, text mining | PubMed |
| A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116551 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and available drugs for oral squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=20